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Abstract
Background: The significance of serum 25-hydroxyvitamin D [25(OH)D] concentrations for hip fracture risk of the elderly is
still uncertain. Difficulties reaching both frail and healthy elderly people in randomized controlled trials or large cohort
studies may in part explain discordant findings. We determined hazard ratios for hip fractures of elderly men and women
related to serum 25(OH)D, including both the frail and the healthy segment of the elderly population.
Methods: The AGES-Reykjavik Study is a prospective study of 5764 men and women, age 66–96 years, based on a
representative sample of the population of Reykjavik, Iceland. Participation was 71.8%. Hazard ratios of incident hip
fractures and baseline bone mineral density were determined according to serum concentrations of 25(OH)D at baseline.
Results: Mean follow-up was 5.4 years. Compared with referent values (50–75 nmol/L), hazard ratios for hip fractures were
2.24 (95% CI 1.63, 3.09) for serum 25(OH)D ,30 nmol/L, adjusting for age, sex, body mass index, height, smoking, alcohol
intake and season, and 2.08 (95% CI 1.51, 2.87), adjusting additionally for physical activity. No difference in risk was
associated with 30–50 nmol/L or $75 nmol/L in either model compared with referent. Analyzing the sexes separately,
hazard ratios were 2.61 (95% CI 1.47, 4.64) in men and 1.93 (95% CI 1.31, 2.84) in women. Values ,30 nmol/L were
associated with significantly lower bone mineral density of femoral neck compared with referent, z-scores -0.14 (95% CI 2
0.27, 20.00) in men and 20.11 (95% CI 20.22, 20.01) in women.
Conclusions: Our results lend support to the overarching importance of maintaining serum 25(OH)D above 30 nmol/L for
bone health of elderly people while potential benefits of having much higher levels could not be detected.
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Introduction
The importance of vitamin D for skeletal health has long been
recognized, and serum 25-hydroxyvitamin D [25(OH)D] is the
generally accepted indicator of vitamin D status. Still, optimal
serum concentration for bone health is a subject of active debate
and intensive research [1]. The Institute of Medicine recently
recommended serum levels of 40–50 nmol/L for most adults,
based on multiple skeletal outcomes [2], while other experts have
suggested levels as high as 75 to 100 nmol/L [3,4].
Several functional indicators are used for vitamin D adequacy
as it relates to bone health of the elderly, including bone mineral
density and prevention of bone loss [5,6], as well as surrogate
measures such as maximal calcium absorption and suppression of
parathyroid hormone levels [4,7]. However, fracture prevention,
and the levels of 25(OH)D associated with decreased fracture risk
may be a more relevant and clinically useful functional marker, as
it relates directly to health and quality of life of the elderly. Still,
associations between circulating 25(OH)D concentrations and
incident fractures in old age remain uncertain [5,6,8]. While
several prospective cohort studies have reported higher risk for
fractures at lower 25(OH)D concentrations [3,9–14], others show
no such association [15–17]. Further, the reported thresholds of
significance for fracture risk are quite varied, ranging from 30–
40 nmol/L (11) to a high of 90–100 nmol/L [3].
Hip fracture risk of the elderly is a function of multiple factors,
including bone mineral density, muscle strength and balance, all of
which have been related to vitamin D status and function [9,18].
In nine out of ten instances, hip fracture is sustained through a fall
[19], and risk of falling has been related to vitamin D status [20].
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Adding to this uncertainty, Randomized controlled trials
(RCTs), often considered to provide the highest quality evidence,
have not shown a consistent benefit from vitamin D supplements
for hip bone mineral density (BMD) or fracture prevention, except
possibly in the institutionalized elderly [21] or when given in
combination with calcium [22]. Conversely, a recent meta-analysis
of RCTs, estimating actual intake of vitamin D rather than
prescribed dose, concluded that intakes $800 IU/day may be
somewhat favorable in the prevention of hip fractures and other
non-vertebral fractures in adults 65 years or older [23].
Given the social and economic burden of hip fractures in the
elderly, prevention and risk reduction are of prime importance.
Sufficient doses of vitamin D for skeletal health in old age need
particular elucidation. However, high-risk groups, such as the frail
elderly, may be difficult to reach in large cohort studies or RCTs
of community-living adults, which in turn may have contributed to
the discordant findings of previous studies.
Here we report on the risk of incident hip fractures in the elderly
related to circulating 25(OH)D concentrations and bone mineral
density in participants in the large prospective AGES-Reykjavik
Study, selected at random from the general population.
Methods
Participants
The Ages Gene/Environment Susceptibility (AGES) -Reykjavik
Study [24] is a follow-up of the population based Reykjavik
Cohort Study, initiated in 1967.
A total of 27,281 men and women, all Caucasians, born in
1907–1935 and residing in Reykjavik and nearby communities
were selected at random from the national registry. From these,
19,381 attended the study during the period 1967 to 1991 [25].
From the 11,549 cohort members still alive when AGES-
Reykjavik Study examinations began in September 2002, 8,030
individuals were randomly chosen and invited to the study. From
these, 5,764 participants, age 66–96 years (mean age 76 years),
had enrolled in the AGES-Reykjavik Study by January 2006
(71.8% of invited), with continuous recruitment throughout the
period. Participants were offered free taxi rides to the clinic at
every visit and personal assistance from the drivers in order to
better reach those with limited mobility.
Ethics statement
Written informed consent was obtained from all participants,
and the study was approved by the Icelandic National Bioethics
Committee (VSN: 00-063) and the National Institute on Aging
Intramural Institutional Review Board (MedStar IRB for the
Intramural Research Program, Baltimore, MD).
Clinical data collection
Extensive data were collected in the AGES-Reykjavik Study
during a series of clinical examinations, according to standardized
study protocols by staff of the Icelandic Health Association. Data
were gathered on smoking, alcohol intake and consumption
frequency of selected foods, including milk and dairy products,
using a validated food frequency questionnaire [26]. Physical
activity was assessed by self-reported level of physical activity
during the last 12 months, where participants were asked how
frequently in times per month, week or day they engaged in
moderate or vigorous activity, giving examples of this level of
activity for clarification. Participants got personal assistance in
answering questions. Quantitative computed tomography (QCT) -
scanning was performed for BMD measurements.
Of the 5,764 participants of AGES-Reykjavik, 303 did not meet
the inclusion criteria, e.g., lacking serum 25(OH)D measurements,
leaving 5461 individuals included in the study, all with available
fracture data. Of these, 679 individuals did not undergo QCT
scanning, leaving 4782 individuals for the analysis of BMD and
vitamin D status.
Measurement of serum 25(OH)D
Blood was collected during the first clinic visit to AGES-study,
from September 2002 to January 2006, and fasting serum samples
were kept frozen at 280uC on-site in the IHA laboratory.
Quantitative determination of total 25(OH) D (D2 and D3) was
conducted by means of a direct, competitive chemiluminescence
immunoassay (CLIA), using the LIAISON 25 OH Vitamin D
Total assay (DiaSorin, Inc., Stillwater, Minnesota). The inter assay
coefficient of variation was ,6.5%, using a previously frozen
serum pool as the control sample and ,12.7% when the
calculated data were from measurements using Liaison quality
controls.
Bone mineral density measurements
During the first clinic visit, QCT measurements, providing true
volumetric density, were taken on the left hip, using a 4-detector
CT system (Sensation, Siemens Medical Systems, Erlangen,
Germany). Using a standardized protocol, scans were obtained
encompassing the proximal femur from a level 1 cm above the
acetabulum to a level 5 mm inferior to the lesser trochanter with
1 mm slice thickness. To calibrate CT Hounsfield units to
equivalent bone mineral concentration, all subjects were scanned
with a calibration phantom (Image Analysis, Columbia, KY,
USA). Further procedures and quality assessments have been
described in detail elsewhere [24,27].
The variables used in the present study are volumetric integral
BMD (mg/cm3), reflecting both trabecular and cortical bone mass,
of the femoral neck and trochanteric region separately. Reasons
for exclusion from the QCT were inability to lie supine, body
weight over 150 kg or having undergone hip replacement surgery.
Fractures
Hip fracture data were recorded, verified and confirmed from
medical and radiological records as previously described [28].
Incident fractures were recorded from participants’ enrollment
into the study until 31st of December 2009, with a mean follow-up
time of 5.4 years (SD 1.5). Hip fractures were defined according to
International Classification of Diseases version 10, diagnostic
codes S72.0, S72.1, S72.2 (WHO 1994). The AGES-Reykjavik
Study fracture registration has been shown to have a capture rate
of about 97% for hip fracture [28].
Statistical analyses
The mean and standard deviation (SD) were used to describe
continuous variables and percentages were used for dichotomous
variables. Serum 25(OH)D was categorized, a priori, into four
groups of ,30, $30–50, $50–75 and $75 nmol/L. The group
$50–75 nmol/L (sufficient level) was used as referent, to establish
whether beneficial effects could be detected at higher levels
($75 nmol/L) and to compare with lower levels, (30–50 nmol/L)
and (,30 nmol/L), concentrations that have been considered
inadequate and depleted, according to the Institute of Medicine
[2]. The absolute BMD values (in mg/cm3) of the femoral neck
and trochanteric area were transformed into a gender-specific z-
score, based on the internal distribution in our study population.
The z-score for femoral neck was used as the primary outcome
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measure when examining the association between 25(OH)D and
BMD, which was performed as a secondary analysis.
Cox Proportional Hazard Model was used when examining the
association between 25(OH)D and bone fractures; and linear
regression when examining the association with bone mineral
density. As a measure of association we used x2-test (Type III) for
dichotomous outcomes and t-test for continuous outcomes under
the null hypothesis that all 25(OH)D groups were equal (p for
effect). For testing linear trend, ordinal values (0,1,2,3) for serum
25(OH)D were entered in the regression model. All of the analyses
were carried out using SAS statistical software (version 9.2, SAS
Institute, Cary, NC).
In our analyses we selected a priori and included the following set
of covariates: age (continuous, no missing), sex (binary, no missing)
height (continuous, 0.1% missing), current smoking (binary, 2.5%
missing), body mass index (BMI) (,18.5, 18.5–24.9, 25–29.9, 30–
34.9, 35–39.9 and 40+, 0.1% missing), current alcohol intake (0,
1–25, 26–50 and 50+ g/day, 3% missing), season (winter: Dec,
Jan, Feb, spring: Mar, Apr, May, summer: June, July, Aug,
autumn: Sept Oct Nov, no missing), current physical activity
(never, rarely, occasionally, moderate, high, 4.0% missing). As self
reported milk and dairy product intake and serum 25(OH)D at
baseline were essentially uncorrelated (Spearman r = 0.06), milk
and dairy product intake was not included as covariate. The
proportion of subjects missing data on one or more covariate was
4.4%. Due to the relatively low number of missing values for most
covariates, missing values were replaced with median (continuous)
and most frequent (dichotomous) values. Two models were used
for covariate adjustment: Model A adjusting for age, sex, smoking,
BMI, height, alcohol intake and season of blood sample collection;
and Model B, additionally adjusting for physical activity.
To check the robustness of our findings with respect to
imputation for missing covariates and length of follow-up we 1)
ran all analyses using complete case analyses (all subjects with
missing covariates excluded); and 2) examined the association
between baseline 25(OH)D with hip fractures, excluding all
fractures occurring within 6 months from baseline.
Results
A total of 261 hip fractures were encountered during a mean
follow-up time of 5.4 years (SD 1.5). Characteristics of the study
participants by sex and serum 25(OH)D are shown in Table 1.
Fourteen per cent of men and 19% of women had serum
25(OH)D concentrations below 30 nmol/L, and 21% and 14%
had concentrations $75 nmol/L, men and women respectively.
There were significant negative trends associated with 25(OH)D
category for the following variables in both men and women: BMI,
% physically inactive, % drinking no alcohol and % smoking,
while positive trends were found for BMD. There was no
significant association between level of serum 25(OH)D and mean
age for men or women.
For males the mean (SD) integral BMD was 254 (51)mg/cm3 for
femoral neck and 250 (50)mg/cm3 for trochanter. The corre-
sponding values for females were 244 (50)mg/cm3 and 226
(48)mg/cm3. The mean (SD) serum 25(OH)D was 57 (25)nmol/L
and 51 (24)nmol/L for males and females, respectively.
Table 2 shows hip fracture hazard ratios according to serum
25(OH)D categories for all participants and for men and women
separately. Compared with referent values of 50–75 nmol/L, the
risk for hip fractures more than doubled in all subjects with levels
below 30 nmol/L, values remaining relatively stable through
adjustment models. Adjusting for age, height and BMI, current
smoking, season of blood sampling and alcohol intake, the hazard
ratio was 2.24 (95% CI 1.63, 3.09) and with further adjustment for
physical activity it was 2.08 (95% CI 1.51, 2.87). No increase in
risk was associated with serum concentrations 30–50 nmol/L
compared with referent values and neither was there any
difference in risk associated with values $75 nmol/L in either
adjustment model. When the sexes were analyzed separately,
hazard ratio for men was 2.61 (95% CI 1.47, 4.64), compared with
1.93 (95% CI 1.31, 2.84) for women in the fully adjusted model.
Again risk ratios did not change significantly between the different
adjustment models in either sex. Values between 30–50 nmol/L
and values $75 nmol/L were not associated with changes in risk
compared with referent values in either sex.
Based on the prevalence of hip fractures in the 50–75 nmol/
group for all subjects (4.0%) we estimated the excess number
of fractures, i.e. expected minus observed fractures, in the
,30 nmol/L group. Expected fractures were 38, or 0.04*938
(number of subjects with ,30 nmol/L), while 77 fractures were
observed. This suggests that 15% (or 39 excess fractures out of 261
in total) may be attributable to poor (,30 nmol/L) serum 25(OH)
D status.
Associations between 25(OH)D concentrations and BMD at
baseline in femoral neck are shown in Table 3, with BMD
reported as z-scores. Using the values 50–75 nmol/L as referent,
values below 30 nmol/L were consistently associated with slightly
lower BMD z-score. In Model A, adjusting for age, height, BMI,
smoking, alcohol intake and season, the adjusted difference in z-
score was 20.18 (95% CI 20.31, 20.04) in men and 20.13 (95%
CI 20.23, 20.03) in women. In model B, additionally adjusting
for physical activity, the corresponding values were 20.14 (95%
CI 20.27, 20.00) and 20.11 (95% CI 20.22, 20.01), men and
women, respectively. No significant difference in risk was
associated with other categories of 25(OH)D concentrations,
except for a small increase at concentrations $75 nmol/L. Taking
both sexes together, there was an increase of 0.10 (95% CI 0.02,
0.18) in Model A, with values remaining stable through further
adjustment. When sexes were analyzed separately, only BMD z-
scores for males remained significantly higher in the $75 nmol/L
group than in the referent. Comparable values were found for
BMD in trochanter associated with 25(OH)D concentrations in
both sexes (data not shown). A total of 679 participants in the study
did not undergo QCT scanning. Associations between hip
fractures and 25(OH)D concentrations in the 4782 individuals
with available scanning data were found to be similar to those
observed in the larger group of 5461 participants.
Figure 1 shows the percentage of incident hip fractures
according to baseline values of 25(OH)D in all participants, during
a mean follow-up time of 5.4 years, mean time to event 3.4 years
(SD1.8). A total of 10.6% of those with values below 15 nmol/L
experienced a fracture, while corresponding proportions were
7.6% and 4.4% for those with values from 15–30 nmol/L and 30–
50 nmol/L, respectively. There was non-significant change in the
percentage at higher 25(OH)D values. However, mean time to
fracture was not significantly different between the 25(OH)D
groups, 3.1 years (SD 1.8) in the lowest category, compared with
3.9 years (SD 3.9), 3.3 years (SD 1.3) and 3.5years (SD 1.6) in the
higher categories.
Finally we found little evidence to suggest that imputing values
for missing covariates may have contributed to residual confound-
ing. As an example, when comparing the referent with,30 nmol/
L for both sexes using model B (Table 2) the hazard ratio for hip
fracture was 2.08 (1.51, 2.87) and was essentially unchanged 2.08
(1.49, 2.91) when subjects with missing covariate information were
excluded. Correspondingly when all individuals with hip fracture
events occurring within 6 months (n = 14) were excluded (using
Vitamin D and Hip Fractures of the Elderly
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imputed covariate values), the hazard ratio was 2.10 (1.51, 2.93).
There was no trend with respect to time to fracture across
categories of 25(OH)D. As an example the mean time to event was
3.1 years (SD 1.8) in the lowest (,30 nmol/L) compared with 3.3
years (SD 1.3) in the referent category (50 -,75 nmol/L).
Discussion
In this prospective cohort study of 5461 elderly people
experiencing a sizable number of hip fractures (n = 261), the
estimated risk of hip fracture was twice as high in individuals with
serum 25(OH)D concentrations below 30 nmol/L, using 50–
75 nmol/L as a referent and adjusting for a series of relevant
cofactors. The risk increase associated with low 25(OH)D levels
was somewhat higher for men than women, but remained stable
and highly significant in both sexes through various adjustments.
No statistically significant difference in risk was associated with
other categories of 25(OH)D concentrations, for levels either
between 30 and 50 nmol/L or above 75 nmol/L, compared with
the referent values.
The relevance of vitamin D status for hip fracture risk has been
considered uncertain in large systematic reviews of vitamin D and
bone health [5,6]. Indeed, several cohort studies have found no
associations between hip fracture risk and vitamin D [15–17],
while some studies have reported risk protection by quite high
serum 25(OH)D concentrations, up to 100 nmol/L [3,10]. Still
others show tendencies for increased risk at low levels below 30–
40 nmol/L, with no further protection at higher concentrations
[9,11,13]. According to a large multi-center study from Norway
[14] there is a moderate increase in risk for hip fractures among
those in the lowest quartile for baseline 25(OH)D (#42.1 nmol/L)
compared with the highest $67.9 nmol/L), with a hazard ratio of
1.34. Also, RCTs are not unequivocal in their conclusions,
regarding either the efficacy or ideal dose of vitamin D
supplements for fracture prevention [21,22,29]. Elucidating the
significance of vitamin D for hip fracture risk of the elderly is of
great public health significance, considering the public health
costs, high mortality and human suffering related to hip fractures
[30]. As vitamin D of varying doses is widely used in clinical
practice to lower the risk of osteoporotic fractures, it is of prime
importance to determine whether relatively high 25(OH)D
concentrations are needed for risk protection, concentrations
which generally require larger doses of vitamin D supplementation
than the 800 IU currently recommended for the elderly by the
Institute of Medicine [2] and recently endorsed in a review of
randomized controlled trials [31]. Even though these higher doses
are not considered toxic, adverse effects, such as increased risk of
kidney stones, have been indicated in studies like the Women’s
Health Initiative [32]. The study of Sanders et al. [33] further
alerts to possible adverse outcomes associated with large doses, as
they reported increased risk for falls and fractures in a group of
elderly people receiving 500,000 IU of vitamin D annually for 3 to
5 years.
Table 1. Characteristics of male and female participants at baseline according to categories of serum 25-hydroxyvitamin D
(N= 5461), mean and SD.
Serum 25-hydroxyvitamin D (nmol/L)
,30 30-,50 50-,75 $75 P value1
Males (n =2346)
n (%) 337 (14%) 638 (28%) 886 (38%) 485 (21%)
Femoral neck BMD, mg/cm3 245 (59) 253 (51) 254 (50) 259 (53) 0.0005
Trochanter BMD, mg/cm3 242 (51) 248 (51) 252 (47) 255 (51) 0.0002
Age in years 76.7 (5.8) 76.8 (5.5) 76.7 (5.4) 76.8 (5.4) 0.65
Height, cm 175.1 (6.2) 175.1 (6.2) 175.5 (6.2) 175.8 (6.2) 0.03
BMI, kg/m2 27.2 (4.3) 27.3 (3.9) 26.7 (3.7) 26.3 (3.5) ,0.0001
% Physically inactive 61 46 37 34 ,0.0001
% Not drinking alcohol 34 30 24 27 0.002
% Current smokers 23 12 8 9 ,0.0001
Females (n=3125)
n (%) 601 (19%) 992 (32%) 1103 (35%) 429 (14%)
BMD for femoral neck (mg/cm3) 240 (50) 245 (52) 245 (49) 248 (48) 0.03
BMD for trochanter (mg/cm3) 221 (49) 227 (50) 227 (46) 229 (45) 0.02
Age in years 76.8 (5.6) 76.7 (5.8) 76.3 (5.7) 76.7 (5.6) 0.20
Height, cm 160.3 (5.7) 160.7 (5.6) 161.1 (5.9) 160.8 (6.1) 0.006
BMI, kg/m2 28.1 (5.5) 27.8 (4.9) 26.6 (4.4) 26.2 (4.3) ,0.0001
% Physically inactive 66 50 45 42 ,0.0001
% Not drinking alcohol 54 41 35 37 ,0.0001
% Current smokers 18 12 11 10 0.0001
1T-test for trend for continuous covariates with serum 25-hydroxyvitamin D entered as ordinal values.
Chi-square test for dichotomous covariates.
doi:10.1371/journal.pone.0091122.t001
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Differences in previous study outcomes have been explained in
part by the different populations under study as well as possible
differences in confounder adjustments [5]. Specifically, the frail
and sickly may not be included or reached in all community-based
studies of the elderly, but lower vitamin D status is consistently
reported among the frail compared with those more physically
active and in better health [3,9]. Thus, the segment of the elderly
population having the lowest 25(OH)D levels may not be included
in many cohort studies and the significance of very low values thus
overlooked or minimized [9,11]. In our study, which was based on
a random sample from the general population, the participation
rate was high, or 71.8%, and the distribution of 25(OH)D
concentration was quite wide, with comparable proportions of the
population having values below 30 nmol/L and above 75 nmol/
L. A significant proportion of all hip fractures in our study (15%),
may thus be attributed to poor or deficient (,30 nmol/L) serum
25(OH)D. Interestingly, this is a comparable proportion to that
reported from combined calcium and vitamin D supplementation
for reducing fracture risk [34]. Possibly the relatively high calcium
intake in our population, due to widespread use of milk and dairy
products, may contribute to this effect [7].
The fracture incidence observed in our study, where both sexes
were taken together for improved statistical power, also strongly
indicates that there is a nonlinear relationship between circulating
25(OH)D and fracture risk, with only small gains being associated
with serum levels above 50 nmol/L. The highest incidence was
observed in the group with 25(OH)D values below 15 nmols, with
steeply decreasing proportion with increased circulating vitamin D
up to 50 nmol/L, but little differences above those concentrations.
While appropriate adjustments were made for season in our
analysis, seasonal variation in 25(OH)D values was less pro-
nounced in the present study than previously reported for younger
populations in Reykjavik, geographically located at 64u N [7]. The
difference in mean values obtained in summer and winter was only
4 nmol/L in this elderly population. The relative lack of seasonal
variation indicates that vitamin D intake may play a more
important role for vitamin D status in this population compared
with younger people. Indeed, cod liver oil, either as liquid or
capsules, is a common supplement in Iceland, with 61% of this
population reporting taking the supplement daily and 13% several
times per week, according to AGES questionnaire. However,
intake of milk or dairy products at baseline was not associated with
vitamin D status in our study. Notably, milk or dairy products
were not fortified with vitamin D during the study period.
We measured volumetric QCT-BMD rather than areal BMD,
but similar associations have been shown between fractures and
BMD using these two measures [35,36]. Similar to many previous
studies [3,12] we found a slight but significant positive trend
between BMD in femoral neck and serum concentrations of
25(OH)D in both sexes. Again, only levels below 30 nmol/L were
consistently significantly different from the referent, which is in
concordance with our results regarding increases in hip fracture
risk below 30 nmol/L. However, according to earlier studies the
observed difference of 0.10-0.16 BMD z-scores might be expected
to be associated with only modest increases in fracture risk [37,38].
The two-fold increase in risk associated with low 25(OH)D in our
study supports the contention that the relationship between
vitamin D and fracture risk may indeed be non-linear [1]. It has
been suggested that vitamin D may reduce fracture rates through
Table 2. Hazard ratios for hip fractures according to serum 25-hydroxyvitamin D categories among all subjects (N = 5461), and
stratified by sex.
Unadjusted Model A2 Model B3
HR (95% CI) HR (95% CI) HR (95% CI)
All Subjects cases/n (%)
,30 nmol/L 77/938 (8.2%) 2.14 (1.57, 2.94) 2.24 (1.63, 3.09) 2.08 (1.51, 2.87)
30–50 nmol/L 71/1620 (4.4%) 1.10 (0.80, 1.52) 1.13 (0.82, 1.56) 1.11 (0.80, 1.53)
50–75 nmol/L 80/1989 (4.0%) 1.00 1.00 1.00
$75 nmol/L 33/914 (3.6%) 0.91 (0.61, 1.37) 0.90 (0.60, 1.35) 0.94 (0.62, 1.41)
P for effect1 ,0.0001 ,0.0001 ,0.0001
Males cases/n (%)
,30 nmol/L 25/337 (7.4%) 2.61 (1.49, 4.58) 2.81 (1.59, 4.96) 2.61 (1.47, 4.64)
30–50 nmol/L 24/604 (3.8%) 1.35 (0.77, 2.36) 1.52 (0.86, 2,67) 1.49 (0.84, 2.63)
50–75 nmol/L 25/886 (2.8%) 1.00 1.00 1.00
$75 nmol/L 14/485 (2.9%) 0.99 (0.51, 1.90) 0.97 (0.50, 1.88) 1.02 (0.53, 1.97)
P for effect1 0.003 0.001 0.006
Females cases/n (%)
,30 nmol/L 52/601 (8.7%) 1.89 (1.29, 2.76) 2.06 (1.40, 3.02) 1.93 (1.31, 2.84)
30–50 nmol/L 47/992 (4.7%) 0.97 (0.66, 1.44) 1.01 (0.68, 1.50) 0.99 (0.67, 1.47)
50–75 nmol/L 55/1103 (5.0%) 1.00 1.00 1.00
$75 nmol/L 19/429 (4.4%) 0.94 (0.56, 1.58) 0.86 (0.51, 1.46) 0.89 (0.53, 1.51)
P for effect1 0.001 0.0002 0.001
Abbreviations: HR Hazard Ratio, CI confidence interval.
1Chi-square test (type 3).
2Adjusted for age at recruitment, sex (when all subjects are included), height, body mass index, current smoking, season of blood sampling and alcohol intake.
3Additionally adjusted for current physical activity.
doi:10.1371/journal.pone.0091122.t002
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Table 3. Differences in z-score (number of SD from age corrected mean) of femoral neck bone mineral density according to serum
25-hydroxyvitamin D categories at baseline (N = 4782).
Unadjusted Model A2 Model B3
D(95% CI) D (95% CI) D (95% CI)
Femoral neck BMD(z-score)
All (N = 4782)
,30 nmol/L 20.13 (20.21, 20.04) 20.15 (20.23, 20.07) 20.13 (20.21, 20.05)
30–50 nmol/L 20.02 (20.09, 0.05) 20.04 (20.11, 0.03) 20.03 (20.10, 0.03)
50–75 nmol/L Referent Referent Referent
$75 nmol/L 0.08 (20.01, 0.16) 0.10 (0.02, 0.18) 0.09 (0.01, 0.17)
P for effect1 0.0006 ,0.0001 0.0001
Males (n = 2104)
,30 nmol/L 20.18 (20.31, 20.04) 20.18 (20.31, 20.04) 20.14 (20.27, 20.00)
30–50 nmol/L 20.02 (20.13, 0.08) 20.04 (20.15, 0.07) 20.03 (20.13, 0.08)
50–75 nmol/L Referent Referent Referent
$75 nmol/L 0.10 (20.02, 0.21) 0.12 (0.01, 0.24) 0.11 (20.01, 0.22)
P for effect1 0.004 0.0009 0.01
Females (n = 2678)
,30 nmol/L 20.10 (20.21, 0.01) 20.13 (20.23, 20.03) 20.11 (20.22, 20.01)
30–50 nmol/L 20.01 (20.11, 0.08) 20.04 (20.12, 0.05) 20.03 (20.12, 0.05)
50–75 nmol/L Referent Referent Referent
$75 nmol/L 0.06 (20.06, 0.18) 0.07 (20.04, 0.19) 0.07 (20.04, 0.18)
P for effect1 0.14 0.01 0.03
Abbreviations: CI confidence interval.
1F-test (type 3).
2Adjusted for age at recruitment, sex (when all subjects are included), height, body mass index, current smoking, season of blood sampling and alcohol intake.
3Additionally adjusted for current physical activity.
doi:10.1371/journal.pone.0091122.t003
Figure 1. Hip fracture incidence (%) during a follow-up of 5.4 years (SD1.5) among AGES participants (N=5461) according to serum
baseline categories of 25(OH)D. Unadjusted values.
doi:10.1371/journal.pone.0091122.g001
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additional mechanisms, independent of bone density [39].
Specifically, vitamin D supplements may effectively decrease the
risk of falling, especially in the institutionally elderly, possibly
through actions involving balance and muscle strength [20,40].
It is well known that elderly men have higher mean BMD and
lower risk for hip fractures than women [14,27], as confirmed in
our study. However, the risk increase associated with low
25(OH)D concentrations was comparable in men and women
suggesting that vitamin D status is no less important for lowering
fracture risk among elderly men than women.
Concerns have been raised over assays for 25(OH)D giving
varying results, casting doubt on the comparability of specific
values for vitamin D status [41]. Our study employed a common
assay method for 25(OH)D, widely used in clinical settings. Thus
we believe that our results are clinically relevant, even though the
levels measured by the CLIA method may be systematically lower
than those measured by HPLC. Furthermore, systematic errors in
absolute serum levels should only affect interpretations of our
findings in terms of absolute cut-off values but should not affect the
magnitude and strength of the observed association.
The length of follow-up may also be a concern, as single
baseline vitamin D values may not represent status many years
later [42]. Indeed, the study by Looker [13] showed that vitamin D
concentrations predicted major osteoporotic fracture risk only for
10 years of follow up. Importantly, our mean follow-up time was
5.4 years, with mean time to event 3.4 years. Frail individuals may
also be selectively advised to take vitamin D supplements,
diminishing observed risk. However, results from our 25(OH)D
analysis were not available until at the end of follow up, and thus
our subjects could not be informed of their status earlier.
The main strength of our study is the large number of elderly
people, displaying a wide variation in serum 25(OH)D values, and
sustaining a total of 261 hip fractures. Thus, robust associations
could be obtained between vitamin D status and fracture risk. The
main limitation to our study, however, is the single baseline
measurement of 25(OH)D. Also, as this is an observational study,
some residual confounding cannot be excluded. However, as
hazard ratios for hip fracture were quite similar in unadjusted and
fully adjusted data in both sexes, residual confounding is not likely
to substantially affect our main results.
To conclude: Our results lend support to the overarching
importance of maintaining serum 25(OH)D above 30 nmol/L for
bone health of elderly people while potential benefits of having
much higher levels could not be detected.
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